Financials

News Discussions Technicals Seasonals

229000 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Gencurix, Inc. is engaged in developing and manufacturing of cancer diagnostic test kits. Its products include GenesWell BCT, GenesWell ddEGFR Mutation Test, GenesWell CDx EGFR Mutation Test, and GenesWell ddEGFR Mutation Test. The company was founded on September 21, 2011 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

229000 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company